Effect of polyriboinosinic-polyribocytidylic acid and antibody on infection of immunosuppressed mice with vaccinia virus.
D000818:Animals; D000914:Antibodies, Viral / Q000008:administration & dosage* / Q000032:analysis; D003520:Cyclophosphamide; D004357:Drug Synergism; D007165:Immunosuppression Therapy; D008297:Male; D051379:Mice; D009500:Neutralization Tests; D011070:Poly I-C / Q000627:therapeutic use*; D011817:Rabbits / Q000276:immunology; D014615:Vaccinia / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D014616:Vaccinia virus / Q000276:immunology* / Q000302:isolation & purification
D000914:Antibodies, Viral; D003520:Cyclophosphamide; D011070:Poly I-C